Surgical excision as primary treatment modality for extensive cervicofacial lymphatic malformations in children

2011 ◽  
Vol 75 (5) ◽  
pp. 673-677 ◽  
Author(s):  
Y. Bajaj ◽  
R. Hewitt ◽  
S. Ifeacho ◽  
B.E.J. Hartley
Keyword(s):  
Treatment Modality ◽  
Surgical Excision ◽  
Primary Treatment ◽  
Lymphatic Malformations ◽  
Primary Treatment Modality

scholarly journals Role of Adjuvant Radiosurgery after Thoracoscopic Microsurgical Resection of a Spinal Schwannoma

2012 ◽  
Vol 2012 ◽  
pp. 1-4
Author(s):  
Toba N. Niazi ◽  
Christian A. Bowers ◽  
Meic H. Schmidt
Keyword(s):  
Stereotactic Radiosurgery ◽  
Treatment Modality ◽  
Surgical Excision ◽  
Primary Treatment ◽  
Benign Tumors ◽  
Noninvasive Treatment ◽  
Thoracic Spinal ◽  
Primary Treatment Modality ◽  
Microsurgical Resection ◽  
Spinal Schwannoma

Stereotactic radiosurgery to benign tumors of the spine has not been advocated as a primary treatment modality because of the favorable prognosis for these lesions after gross-total resection. There is even less evidence regarding its use as an adjuvant to neurosurgical resection of benign recurrent spinal disease. We describe the case of a 30-year-old man with a thoracic spinal schwannoma who had an interval increase of his lesion five months after thoracoscopic microsurgical resection. The patient opted for noninvasive stereotactic radiosurgery in lieu of additional surgical excision and has had stable disease 15 months after radiosurgical treatment with the linear accelerator (LINAC) system. In this setting, stereotactic radiosurgery provided a useful adjunct to thoracoscopic microsurgical resection. Future Class I and II evidence should be sought to evaluate the utility of stereotactic radiosurgery as a primary treatment modality or as an adjuvant for microneurosurgical resection of benign spinal lesions in patients who want noninvasive treatment after disease recurrence or who harbor medical comorbidities that would preclude them from being safe surgical candidates.

scholarly journals Cervicofacial lymphatic malformations: diagnosis and management

2021 ◽  
Vol 37 (1) ◽  
Author(s):  
Rachida Bouatay ◽  
Badii Hmida ◽  
Malek Hajjej ◽  
Amira Farhati ◽  
Khaled Harrathi ◽  
...  
Keyword(s):  
Head And Neck ◽  
Lymphatic Vessels ◽  
Neck Region ◽  
Surgical Excision ◽  
Primary Treatment ◽  
Benign Tumors ◽  
Lymphatic Malformations ◽  
Therapeutic Modalities ◽  
Sclerosing Agents ◽  
Primary Treatment Modality

Abstract Background Lymphatic malformations are rare benign tumors that result from congenital and acquired alterations of the lymphatic vessels. They occur most commonly on the head and neck region. The aim of this study is to describe clinical profiles of lymphatic malformations of the head and neck (LMHN) as well as to study therapeutic modalities through our series and review of the literature. Results This is a retrospective record-based descriptive study conducted in the ENT and the Radiology departments over a 17-year period. Our study included twelve patients, aged between 8 months and 52 years. Two swellings were present at birth and had not been prenatally diagnosed in both cases. One patient was affected by TRISOMY 21. All patients consulted for a painless mass of the head or neck. Seven masses were located in the suprahyoid region and five in the infrahyoid region. Ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) were realized to establish the diagnosis and assess the extent of the lesions. Surgical excision was performed in 7 patients. It was complete in 6 patients. Five patients were treated with sclerotherapy. The sclerosing agents used were Aetoxisclerol 2%, hypertonic saline, and absolute alcohol. One patient had a reversible paresis of the left mental nerve after surgery. An excellent response to sclerotherapy with complete resolution was obtained in 3 cases with no recurrence of the disease. Conclusions Surgical excision has been the management option of choice for LMHN. The recent advances in sclerotherapy make it safe and effective as a primary treatment modality for these lesions.

Glossopharyngeal Neuralgia

2019 ◽  
pp. 23-30
Author(s):  
Oren Sagher
Keyword(s):  
Weight Loss ◽  
Trigeminal Neuralgia ◽  
Microvascular Decompression ◽  
Medical Management ◽  
Treatment Modality ◽  
Primary Treatment ◽  
Glossopharyngeal Neuralgia ◽  
Pain Condition ◽  
Primary Treatment Modality ◽  
Posterior Tongue

Glossopharyngeal neuralgia is an uncommon, but devastating pain condition. It shares many features with trigeminal neuralgia, but predominantly affects the posterior tongue and pharynx. Since glossopharyngeal neuralgia pain is frequently triggered by swallowing or movement of the tongue, patients frequently present with weight loss and dehydration. This chapter describes the classic features of this condition, including its association with syncope. The medical management of glossopharyngeal neuralgia is outlined as a primary treatment modality. Surgical considerations are also described, including microvascular decompression or sectioning of the glossopharyngeal nerve. Surgical pearls for both of these procedures are outlined, as well as strategies for complication avoidance and management.

scholarly journals Gastrointestinal Stromal Tumours: A 10 Year Multicenter Audit

2016 ◽  
Vol 6 (1) ◽  
pp. 1
Author(s):  
Geoffrey Alan Watson ◽  
D. Kelly ◽  
E. Malone ◽  
J. Gleeson ◽  
G. McEntee ◽  
...  
Keyword(s):  
Imatinib Mesylate ◽  
Progressive Disease ◽  
Surgical Excision ◽  
Primary Treatment ◽  
Gi Tract ◽  
Gastrointestinal Stromal Tumours ◽  
First Line ◽  
Primary Treatment Modality ◽  
Tertiary Hospitals ◽  
Personalised Treatment

Background: Gastrointestinal stromal tumours (GISTs) are unique neoplasms of the gastrointestinal (GI) tract. The development of targeted therapeutic agents such as imatinib mesylate (Glivec) has altered the way on how we now manage these rare malignancies. The aim of this study was to evaluate the management of GISTs in three Irish tertiary hospitals. Methods: We performed a retrospective, multicenter audit of patients diagnosed with gastrointestinal stromal tumours over a ten year period (2005-2015). Results: 110 patients were included in the study. Abdominal pain was the most common presenting symptom, reported in 30% of patients, while 31% were incidental findings. The stomach was the most common primary site of disease, observed in 77% of cases. 15 patients had metastatic disease at the time of diagnosis (14%), and 10 of these patients had liver involvement. More than half of patients (61%) were managed with surgical excision alone (61%), while 24 were managed with surveillance and 28 patients treated with adjuvant Glivec, which was generally well tolerated. 18 patients (20%) demonstrated recurrent or progressive disease after first line treatment. 102 patients (93%) are alive today. Conclusion: While surgery is widely regarded as the primary treatment modality for GISTs the addition of imatinib mesylate has enabled physicians to deliver more personalised treatment while optimising patient outcomes.

Symptom burden among head and neck cancer patients in the first year after diagnosis: Association with primary treatment modality

Oral Oncology ◽  
2019 ◽  
Vol 99 ◽  
pp. 104434 ◽  
Author(s):  
Catherine O. Allen-Ayodabo ◽  
Antoine Eskander ◽  
Laura E. Davis ◽  
Haoyu Zhao ◽  
Alyson L. Mahar ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Treatment Modality ◽  
Symptom Burden ◽  
Primary Treatment ◽  
First Year ◽  
Primary Treatment Modality

Treatment of temporal artery pseudoaneurysms

Vascular ◽  
2013 ◽  
Vol 22 (4) ◽  
pp. 274-279 ◽  
Author(s):  
Irene Thomassen ◽  
Elisabeth G Klompenhouwer ◽  
Edith M Willigendael ◽  
Joep AW Teijink
Keyword(s):  
Superficial Temporal Artery ◽  
Surgical Excision ◽  
Temporal Artery ◽  
Primary Treatment ◽  
Treatment Modalities ◽  
Diagnostic Process ◽  
Thrombin Injection ◽  
Invasive Treatment ◽  
Artery Pseudoaneurysm ◽  
Primary Treatment Modality

Purpose To give an overview of the etiology and diagnostic process of superficial temporal artery pseudoaneurysms and to evaluate different treatment modalities. Basic methods PubMed was used for searching multiple databases for relevant clinical studies. Principal findings A total of 62 studies were included, harboring 82 patients. Surgical excision is the most frequently described treatment, but less invasive treatment modalities as coiling and thrombin injections are gaining popularity. Surgical treatment was successful in all cases (67/67). Endovascular treatment was successful in 69% (9/13); the five cases treated with thrombin injection were all successful. Complementary, a description of our experience with thrombin injection is given. Conclusions Limited evidence of minimal invasive treatment for superficial temporal artery pseudoaneurysm is available. Based on this review combined with our limited experience, we suggest thrombin injections to be considered as the future primary treatment modality. In the case of unsuccessful exclusion of the aneurysm, surgical excision can be performed.

Sign in / Sign up

Export Citation Format

Share Document